Skip to main content
CDC Website

Global Resilience Against Drug-Resistant Tuberculosis (GRAD-TB)

The goal of this Activity is to support USAID TB countries to improve DR-TB detection, treatment, and prevention through the development and implementation of innovative approaches and practices, and the provision of specialized technical assistance to the local partners and National TB programs. Additionally, the Activity will support countries to fulfill their commitments set at the 2023 UNHLM on TB in line with WHO’s End TB Strategy and USAID’s Global TB Strategy 2023-2030. As a result, this Activity will reduce the DR-TB burden through improved rapid detection, treatment, and prevention activities, while building a sustainable and resilient system using local organizations and approaches that are equitable, inclusive, and accessible.

Funding Organization:
The US Agency for International Development
Funding Category:
Other Health-Related
TB
Support Types:
Cooperative Agreements
Locations:
International
Eligible Organizations:
Minimum Amount:
$0
Maximum Amount:
$90,000,000
Fund ID:
7200AA24RFA00009
Application Due Date:
Subjects:
Health Care Planning
Health Care Programs/Services
Medical Treatments and Therapies
TB
TB Prevention
Technical Assistance
Audiences:
At Risk Persons
Community Based Organizations
Health Professionals
Health Services Organizations
Persons with TB
Application Contact
Jackie
Ramanitrera
Senior Acquistion & Assistance Specialist
2408498966
jramanitrera@usaid.gov